Hanai Ko, Babazono Tetsuya, Iwamoto Yasuhiko
Division of Nephrology and Hypertension, Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo 162-8666, Japan.
Diabetes Res Clin Pract. 2008 Feb;79(2):318-24. doi: 10.1016/j.diabres.2007.08.032. Epub 2007 Nov 5.
The association between metabolic syndrome (MS) and renal outcomes in diabetic patients remains unclear. We conducted a cross-sectional study to assess the association between MS and albuminuria and decreased glomerular filtration rate (GFR) in type 2 diabetic patients.
We studied a total of 1003 adult Japanese patients with type 2 diabetes, 582 men, with a mean (+/-S.D.) age of 62+/-12 years. Patients with macroalbuminuria, defined as a urinary albumin-to-creatinine ratio (ACR) > or =300 mg/g Cr, and those with renal insufficiency, defined as serum creatinine > or =2.0 mg/dl, were excluded. MS was assessed according to Japanese definition proposed in 2005. Microalbuminuria and decreased GFR were defined as ACR of 30-299 mg/g Cr and estimated GFR <60 ml/min/1.73 m(2), respectively.
The prevalence of microalbuminuria was significantly higher in patients with MS than those without. In contrast, the prevalence of decreased GFR was comparable between patients with and without MS. Waist circumference was selected as a significant variable in the logistic regression analysis for microalbuminuria.
Microalbuminuria, but not decreased GFR, is independently associated with MS and solely with increased waist circumference in Japanese patients with type 2 diabetes.
糖尿病患者中代谢综合征(MS)与肾脏预后之间的关联仍不明确。我们开展了一项横断面研究,以评估2型糖尿病患者中MS与蛋白尿及肾小球滤过率(GFR)降低之间的关联。
我们共研究了1003例成年日本2型糖尿病患者,其中582例为男性,平均(±标准差)年龄为62±12岁。排除尿白蛋白肌酐比值(ACR)≥300mg/g Cr的大量蛋白尿患者以及血清肌酐≥2.0mg/dl的肾功能不全患者。根据2005年提出的日本定义评估MS。微量白蛋白尿和GFR降低分别定义为ACR为30 - 299mg/g Cr和估计GFR<60ml/min/1.73m²。
MS患者中微量白蛋白尿的患病率显著高于无MS患者。相比之下,有和无MS患者中GFR降低的患病率相当。腰围在微量白蛋白尿的逻辑回归分析中被选为显著变量。
在日本2型糖尿病患者中,微量白蛋白尿而非GFR降低与MS独立相关,且仅与腰围增加有关。